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Abstract
Ovarian folliculogenesis in mammals from the constitution of primordial follicles up to ovulation is
a reasonably well understood mechanism. Nevertheless, underlying mechanisms that determine
the number of ovulating follicles were enigmatic until the identification of the fecundity genes
affecting ovulation rate in sheep, bone morphogenetic protein-15 (BMP-15), growth and
differentiation factor-9 (GDF-9) and BMP receptor-1B (BMPR-1B). In this review, we focus on the
use of these sheep genetic models for understanding the role of the BMP system as an intra-ovarian
regulator of follicular growth and maturation, and finally, ovulation rate.
Introduction
The general mechanism of ovarian folliculogenesis in
mammals is reasonably well understood, implying a com-
plex endocrine dialog between the central nervous system
and the ovary, and various intraovarian paracrine regula-
tions. However, in female mammals, the underlying
mechanisms that control the number of ovulating follicles
in each oestrus cycle, i.e. the ovulation rate, are still poorly
understood. Women, cattle, goats and ewes have generally
one or two offspring, whereas other mammals, such as
rodents, dogs or sows are highly prolific and produce four
or more offspring. However, in sheep, a large range in lit-
ter size has been observed among different breeds and
within breeds. Genetic studies in sheep have indicated
that the ovulation rate and litter size can be genetically
regulated either by a set of different genes each having a
small effect as in the Romanov breeds [1], or alternatively
by the action of single genes with major effect, named
fecundity (Fec) genes (reviewed in [2]). In this respect,
sheep has been considered as a model species to identify
genes involved in mechanisms controlling ovulation rate.
Thus, for the last past two decades, geneticists have created
informative families for segregation studies and fine map-
ping for some of the major genes affecting ovulation rate.
Concomitantly, physiologists have largely investigated
endocrine regulations of the reproductive axis (hypotha-
lamus-pituitary-ovary) in low, compared to high ovula-
tion rate breeds. The common goal was to identify key
genes and physiological regulations that determine ovula-
tion rate in ovine species. The purpose of this review is to
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highlight the use and the study of ovine breeds with dif-
ferent prolificacies that have led to the identification of
genes of the Bone Morphogenetic Protein (BMP) system
with unexpected role in the control of ovarian follicular
growth and ovulation rate.
Identification of the fecundity genes affecting 
ovulation rate in sheep
BMP-15 and GDF-9
Among the dozen of major genes presently known to
affect ovulation rate in sheep [2], Inverdale and Hanna
were the first mutations that have been identified [3]. The
Inverdale gene (FecX) was identified in a flock of Romney
sheep in New Zealand. Based on the inheritance pattern,
it was predicted the presence of a major gene carried by
the X chromosome [4]. One copy of the Inverdale allele
(FecXI) increases ovulation rate by 0.8 and enhance both
the number and LH sensitivity of antral follicles in ovaries
[5]. In contrast, homozygous Inverdale ewes (FecXI/FecXI)
are sterile with small underdeveloped ovaries containing
follicles with no more than one layer of granulosa cells
[6,7]. The FecXI allele corresponds to a single T to A tran-
sition at nucleotide position 896 in the cDNA coding for
the Bone Morphogenetic Protein-15 (BMP-15), also
known as Growth and Differentiation Factor-9b (GDF-
9b). This mutation causes a non-conservative substitution
of valine with aspartic acid at amino acid 299 of the
unprocessed peptide (amino acid 31 of the mature pro-
tein, V31D, Table 1). Galloway et al. [3] also described the
identification of the Hanna mutation (FecXH) showing
the same inheritance pattern and phenotype as the Inver-
dale [8]. Interestingly, the FecXH allele corresponds also to
a single mutation C to T at nucleotide position 871, in the
BMP-15 coding sequence. The Hanna mutation intro-
duces a premature stop at the amino acid position 291 of
the unprocessed peptide (amino acid 23 in mature pro-
tein, Q23stop) leading likely to a loss of bioactivity of the
BMP-15 protein produced by the FecXH allele.
More recently, two new mutations in the BMP-15 gene
and one in the closely related GDF-9 gene have been
described in Belclare and Cambridge sheep [9]. The addi-
tional mutations in BMP-15 named FecXG (Galway) and
FecXB (Belclare) are a C to T and a G to T transitions at
nucleotides 718 and 1100, respectively. FecXG causes a
premature stop codon at amino acid 239 of the unproc-
essed protein (no mature protein) and FecXB substitutes a
serine with an isoleucine at amino acid position 367 of
the unprocessed peptide (amino acid 99 of the mature
protein, S99I, Table 1). The ovarian phenotype in animals
homozygous for these mutations in BMP-15 is indistin-
guishable from the Inverdale phenotype [10]. The muta-
tion  FecGH  (High fertility) in the GDF-9 gene on
chromosome 5 is a C to T transition at position 1184 of
the cDNA substituting a serine for a phenylalanine at posi-
tion 77 of the mature peptide (S77F, [9]). Even if FecGH/
FecGHewes are infertile, ovarian follicles develop to an
abnormal type 5 early antral stage [10], differing from the
phenotype of homozygous FecX carriers where follicles
are blocked at the primary stage.
Finally, a new autosomal major gene affecting ovulation
rate has been evidenced in the French Lacaune breed [11].
The FecL locus has been mapped on sheep chromosome
11 [12,13] and the fine mapping is in progress to identify
the gene. However, in the Lacaune population, ewes with
extremely high ovulation rate have been observed and it
has been hypothesized that another mutation is segregat-
ing in this population. In fact, a new mutation, named
FecXL, was recently identified in the BMP-15 gene. It cor-
responds to a G to A transition at nucleotide 1196 of the
cDNA, replacing a cysteine with a tyrosine at position 53
of the mature protein (C53Y; [13]). FecXL/FecXLho-
mozygous ewes present the same "streak" ovaries pheno-
type than Inverdale homozygous ewes, with follicles
blocked at the primary stage (L. Bodin, S. Fabre, P. Mon-
get, unpublished observation).
BMPR-1B
Booroola was the first major gene that has been reported
to increase ovulation rate [13,14]. The hyperprolific phe-
notype of the Booroola ewes appeared in a breeding of
Table 1: Identified major genes affecting ovulation rate in sheep
Name Gene (Chromosome) allele Mutation pro/mature 
protein
Founder breed Reference
Inverdale BMP-15 (X) FecXI V299D/V31D Romney [3]
Hanna FecXH Q291stop/Q23stop Romney [3]
Belclare FecXB S367I/S99I Belclare [9]
Galway FecXG T239stop/no Belclare, Cambridge [9]
Lacaune X-linked FecXL C321Y/C53Y Lacaune [13]
High Fertility GDF-9 (5) FecGH S395F/S77F Belclare, Cambridge [9]
Booroola BMPR-1B (6) FecBB Q249R Merino, Garole, 
Javanese, Hu, Han
[21–25]
GenBank accession numbers: BMP-15 (AH009593); GDF-9 (AF078545); BMPR-1B (AF312016)Reproductive Biology and Endocrinology 2006, 4:20 http://www.rbej.com/content/4/1/20
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Australian Merino sheep. It is due to the action of a single
autosomal gene (FecB), which influences the number of
ovulations per estrous cycle. Ewes which are homozygous
FecBB/FecBB, heterozygous FecBB/FecB+ and non-carriers
FecB+/FecB+ of the FecBB Booroola mutation can be segre-
gated on the basis of ovulation rate recording of 5 or
more, 3 or 4 and 1 or 2, respectively [15,16]. This increase
in ovulation rate of FecBB carriers is associated with a pre-
cocious maturation of a large number of antral follicles
that ovulate at a smaller size than non-carrier follicles [17-
19]. Moreover, the dynamics of final follicular growth is
changed in FecBB carrier ewe since preovulatory follicles
reach their maximal size early in the follicular phase and
remain at a plateau until ovulation [20]. In 2001, three
independent groups published simultaneously the muta-
tion responsible for the hyperprolific phenotype of the
Booroola ewes [21-23]. The FecBB allele corresponds to a
single mutation in the coding sequence of the Bone Mor-
phogenetic Protein Receptor-type 1B (BMPR-1B), also
known as Activin-like kinase receptor-6 (ALK-6), on ovine
chromosome 6 (Table 1). The G to A transition at nucle-
otide position 746 of the cDNA induces a non-conserva-
tive substitution of a glutamine with an arginine at
position 249 of the protein (Q249R).
After identification of these mutations, several known
prolific breeds have been screened for FecXI and FecBB.
FecXI was not found in any of the breeds tested, but FecBB
was present in the Indian Garole, Indonesian Javanese as
well as Chinese Hu and Small-tailed Han breeds of sheep
[24,25].
In conclusion, these observations point out the BMP-15
gene as a mutational "hot spot" in sheep with already 5
different mutations identified (Table 1). Together with the
identification of the mutated GDF-9 and BMPR-1B genes,
all belonging to same cellular signaling system, these
results highlight the importance of the BMP peptides in
the regulation of ovulation rate. Additionally, the fact that
all these mutations in sheep are associated with increased
ovulation rate without a drastic change in gonadotropins
secretion [26] indicates that BMPs would act essentially as
paracrine and/or autocrine regulators of ovarian follicular
development and growth [27].
The bone morphogenetic protein system
The BMP system belongs to the Transforming Growth Fac-
tor ß (TGFß) superfamily of growth factors and receptors,
along with Growth and Differentiation Factors (GDF),
activin/inhibin peptides, Anti-Mullerian Hormone
(AMH) and the Myostatin protein. The BMP factors act
through two subtypes of single transmembrane domain
receptors with serine-threonine kinase activity. Alk-2, 3
and 6 act as type 1 receptors for BMP factors, whereas BMP
receptor-2 (BMPR-2), Activin receptor-2 and 2B (ActR-2,
ActR-2B) are type 2 receptors. Dimeric BMP molecules
interact with heterotetrameric complexes of type 1 and
type 2 receptors. Within each complex, the constitutive
kinase activity of the type 2 receptor phosphorylates the
type 1 receptor. Once phosphorylated, the type 1 receptor
recruits and phosphorylates intracellular signaling mole-
cules of the Smad proteins family. The phosphorylated
BMP receptor-regulated Smads (Smad 1, 5, or 8) interact
with the common Smad 4 and translocate to the nucleus
where these hetero-complexes act as transcriptional fac-
tors or co-factors to regulate target genes expression
(reviewed in [28]).
Within this general mechanism, it has been shown that
FecX/BMP-15 exhibits the highest affinity for the FecB/
BMPR-1B/Alk-6 and the BMPR-2 receptors, consistent
with the activation of the BMP-specific Smad 1 signaling
pathway [29]. In contrast, FecG/GDF-9 induces the phos-
phorylation and the activation of the TGFß/activin-spe-
cific Smad 2 signaling pathway by interacting with an
unusual BMPR-2/Alk-5 receptor complex [30,31]. Thus,
BMPR-1B could act as a potent receptor for BMP-15 but
not GDF-9. However, GDF-9 and BMP-15 are likely to
cooperate since they can form homodimers and het-
erodimers when produced in the same cell in culture [32].
Expression of the BMP system in the sheep ovary
The expression of the three fecundity genes has been
observed in the sheep ovary. Oocytes are the only sources
of GDF-9 and BMP-15 [33]. The BMP receptor BMPR-1B
is expressed by granulosa cells and oocytes from the pri-
mary to the late antral follicle stages (Fig. 1), and to a
lesser extent, by the theca layer of ovine and bovine antral
follicles [23,34,35]. These three genes are not the only
genes of the BMP signaling system expressed in the ovary.
Among about twenty molecules of the BMP/GDF sub-
group of TGFß superfamily [36], mRNA for BMP-2, BMP-
4, BMP-6 and BMP-7 have been detected in sheep ovary
[37]. BMP-4 and BMP-7 mRNA are expressed by granulosa
and theca cells, whereas BMP-2 mRNA is only expressed
by granulosa cells and BMP-6 mRNA by oocytes [37]. In
bovine antral follicles, Glister et al. [35] have detected the
presence of BMP-4 and BMP-7 proteins in theca cells
whereas granulosa cells and oocyte selectively express
BMP-6. Among the family of BMP receptors, the BMPR-
1A/Alk-3 receptor, closely related to BMPR-1B, and the
BMPR-2 receptor are expressed mainly in the granulosa
cells of primary to late antral follicles in sheep ovary [34].
The presence of ActR-1A, ActR-2 and ActR-2B has also
been detected in bovine antral follicles [35]. Moreover,
the intracellular downstream signaling Smad 1 protein
has been detected in ovine and bovine granulosa cells
[35,38], and Smad 2 has been detected in bovine granu-
losa and theca cells [35,39]. The nature and localization ofReproductive Biology and Endocrinology 2006, 4:20 http://www.rbej.com/content/4/1/20
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Immunostaining for BMPR-1B in sheep ovary Figure 1
Immunostaining for BMPR-1B in sheep ovary. Photomicrographs of primordial (a, e), primary (b, f), small antral (c, g) 
and large antral follicles (d, h). The photomicrographs (a-d) correspond to immunostaining with anti-BMPR-1B rabbit polyclonal 
antibody (1/1000; R&D Systems). The photomicrographs (e-h) correspond to immunostaining with control rabbit IgG.
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these BMP family members within the ruminant ovary
seem similar to those described in rodents [40,41].
Recently, expression of the three Fec genes, BMP-15, GDF-
9 and BMPR-1B, has been detected by RT-PCR analysis
during ovarian development in fetal sheep [42]. Among
the three genes, BMPR-1B is the most precociously
expressed, as early as 25 days post-coïtum (dpc) before the
gonadal sex differentiation. BMPR-1B expression signifi-
cantly increases at 56 dpc at the time of germinal cell mei-
osis. GDF-9 transcripts are detected at 56 dpc and fully
expressed at 75 dpc at the time of primordial follicles for-
mation. Accordingly, the expression of GDF-9 has been
observed in oocytes of type 1-1a follicles [10,33,43]. BMP-
15 transcripts are detected only from 94 dpc that corre-
sponds to the appearance of the first growing follicles.
This is in agreement with the observation of BMP-15
expression in oocytes from primary type 2 follicles [3,10].
Interestingly, the absence of expression of GDF-9 and
BMP-15, and the slight expression of BMPR-1B in the
developing testis compared to ovary [42] may be in favor
of a lower incidence of the BMP system in testicular func-
tion, in agreement with the absence of an altered repro-
ductive phenotype in male carriers of the mutated Fec
genes. The transcripts of BMP-4, BMPR-1A, BMPR-2,
Smad 1, 4 and 5 are also detected as early as 32 dpc in the
developing ovine ovary (B. Mandon-Pépin, S. Fabre,
unpublished data).
Collectively, these data indicate that a complete BMP sig-
naling system is present in ruminant ovaries from fetal to
adulthood stage. Thus, it may exert autocrine and para-
crine actions in the formation and the development of
ovarian follicles. Numerous BMP growth factors are
expressed specifically or mainly by the oocyte (BMP-15,
GDF-9 and BMP-6), the others being expressed by the
somatic follicular cells (BMP-2, BMP-4 and BMP-7). All
the cellular compartments of the follicle, especially the
granulosa cells, are equipped with BMP receptors and
then, are targets of BMP biological action.
The role of sheep fecundity genes in 
folliculogenesis
FecX/BMP-15
Recombinant BMP-15 increases the proliferation of gran-
ulosa cells from rat [44,45] and human [46]. Additionally,
in granulosa cells, BMP-15 potently stimulated mRNA
encoding Kit ligand a factor that is necessary for oocyte
growth in preantral follicles. Thus, both BMP-15 and Kit
ligand play important roles in early follicular growth [47].
Furthermore, BMP-15 is able to modulate steroidogenesis
of granulosa cells. Indeed, in the rat, BMP-15 selectively
modulates the biological effects of FSH on granulosa cells
by inhibiting FSH-induced progesterone production with-
out affecting FSH-induced oestradiol synthesis [44]. The
underlying mechanism implies the down-regulation of
the FSH receptor [48] leading to the suppression of mRNA
accumulation of numerous FSH-dependent genes such as
steroidogenic acute regulatory protein (StAR), P450 side
chain cleavage enzyme (P450scc), 3ß-hydroxysteroid
deshydrogenase (3ß-HSD), LH receptor and inhibin/
activin subunits [49]. In the sheep, BMP-15 also increases
proliferation rate [50] and suppresses basal and FSH-
induced progesterone secretion by granulosa cells from
small antral follicles (Fig. 2).
FecG/GDF-9
Like BMP-15, the closely related oocyte growth factor
GDF-9 is a potent stimulator of granulosa cells prolifera-
tion in the rat [45,51]. However, some effects on rodent
granulosa cells are different from those of BMP-15, likely
due to the use of different signaling pathways. Firstly,
GDF-9 has been shown to inhibit Kit ligand expression
[52,53]. Secondly, GDF-9 inhibits both FSH-induced pro-
gesterone and oestradiol production [51] while it
enhances basal progesterone secretion associated with up-
regulation of the StAR gene [52], acting via a prostaglan-
din E2 pathway [54]. Moreover, GDF-9 decreases LH
receptor mRNA synthesis and also exerts specific effects
on cumulus cells since it induces cumulus expansion and
enhances hyaluronan synthase 2 (HAS2) and cyclooxyge-
nase 2 (COX-2) expression [52]. Additionally, GDF-9 is
able to stimulate androgen biosynthesis by thecal cells in
the rat [55]. Even if BMP-15 and GDF-9 do not use the
same signaling pathway, as said above, these two factors
were shown to co-operate in enhancing granulosa cell
proliferation, increasing inhibin production and sup-
pressing progesterone secretion [45].
In the sheep, we have observed a potent action of GDF-9
on suppressing both basal and FSH-stimulated progester-
one production by ovine granulosa cells from small antral
follicles (Fig. 2), with proliferation being unaffected (Fig.
3).
FecB/BMPR-1B
BMPR-1B has been described as a potent receptor for var-
ious BMP factors [56]. Among them, BMP-15 but also
BMP-2, -4, -6 and BMP-7 are all present within the ovary.
Then, to understand the role of BMPR-1B in the ovary, it
is important to establish the biological effect of its poten-
tial ligands on granulosa cells, theca cells and oocytes, all
expressing BMPR-1B. In sheep granulosa cells from small
antral follicles, BMP-2, 4, and 6 all inhibit both basal and
FSH-stimulated progesterone production (Fig. 2). The
inhibitory effect of BMP-4 on progesterone secretion is
associated with a decrease in expression of StAR, 3ß-HSD
and P450scc genes at the mRNA and protein levels
[38,57]. The underlying mechanism implies a decrease in
FSH-induced cAMP production as well as a decrease inReproductive Biology and Endocrinology 2006, 4:20 http://www.rbej.com/content/4/1/20
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Progesterone secretion by sheep granulosa cells Figure 2
Progesterone secretion by sheep granulosa cells. Granulosa cells from small antral follicles of 1–3 mm in diameter were 
cultured for 96 h in serum free media in the presence or absence of FSH (10ng/ml), in combination with varying concentrations 
of recombinant human BMP-2, BMP-4, BMP-6 (each from R&D Systems), BMP-15 [46] or rat GDF-9 [76]. Each combination of 
treatments was tested in triplicate in each of 4 independent experiments. Results represent progesterone secretion by 50,000 
granulosa cells between 48 h and 96 h of culture. Data are expressed as percentages (mean ± SEM) of the amount of proges-
terone secreted by cells cultured in control condition. Different letters denote significant difference (p < 0.05).
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cAMP biological effects possibly on Steroidogenic factor-
1 (SF-1) transcriptional activity, which is inhibited by
Smad 1 [38]. In contrast, BMP-2, 4 and 6 enhance gona-
dotropin-induced oestradiol production [34,58]. The
same effects, negative on progesterone and positive on
oestradiol, have been observed for BMP-4, 6 and 7 using
bovine granulosa cells in basal and Insulin-like growth
factor-I (IGF-I)-stimulated conditions [35]. In addition,
BMP-4 inhibits LH-dependent production of progester-
one by granulosa cells from preovulatory follicles (A.
Pierre and S. Fabre, unpublished data). Among the differ-
ent BMP factors tested, only BMP-4 appears to increase
ovine granulosa cell proliferation (Fig. 3) [57]. In the rat,
BMP-7 represents also a potent stimulator of granulosa
cells proliferation [59]. Additionally, BMP-2, 4 and 6 are
able to decrease LH-induced androstenedione production
by ovine theca cells [58]. Accordingly, BMP-4, 6 and 7
suppress basal and LH-induced androgen production by
bovine theca cells [39]. These factors are also potent stim-
ulators of theca cell number and proliferation [39,58].
Steroids are not the only secretion products of follicular
cells that are affected by the action of BMPR-1B ligands.
Indeed, BMP-2 enhances inhibin-B production in human
granulosa-luteal cells [60] and inhibin-A secretion by
ovine granulosa cells [34]. Moreover, BMP-4, 6 and 7 have
been shown to increase inhibin-A, activin-A and follista-
tin production by bovine granulosa cells [35].
The oocyte could be considered as a target cell for BMPR-
1B ligands. However, BMP-2 and BMP-4 do not affect
oocyte nuclear maturation, cumulus cell expansion, or
blastocyst formation following IVF in the bovine species
[61].
Collectively, these results indicate that fecundity genes are
implicated in mechanisms regulating granulosa and theca
cells proliferation and differentiation. Along the folliculo-
genesis process, FecX, FecG and FecB genes likely control
the early steps when follicular growth is closely linked to
granulosa cell proliferation. At later stages of follicular
development, in antral follicles, Fec genes would likely
modulate the differentiative effect of FSH, and possibly
IGF-I, on follicular cells. Finally, in gonadotropin-
dependent large antral follicles, Fec genes control follicu-
lar cells differentiation and exert a dramatic negative
action on FSH and LH-dependent progesterone produc-
tion. Thereby, they might be implicated in delaying the
luteinization process in follicular cells before the time
when ovulation and luteinization are triggered by the pre-
ovulatory gonadotropin surge.
How do mutations in sheep fecundity genes 
affect the ovulation rate?
To answer this question, one has to know the functional
consequences of the mutations in the normal biological
activity of proteins produced by fecundity genes. Obvi-
ously, in the case of the FecX/BMP-15 gene, FecXH and
FecXG create STOP codon and then would impair the pro-
duction of biologically active mature BMP-15. Interest-
ingly, the resulting ovarian phenotype is
indistinguishable from the phenotype observed with the
other three single mutations FecXI, FecXB and FecXL, likely
enabling the complete peptide production as described
for FecXI and FecXB [32,62]. Thus, these mutations, as well
as FecXH and FecXG, can be considered as complete "loss of
function" mutations for BMP-15. The precise molecular
mechanism by which these mutations impair BMP-15
activity is still unclear. It may affect either the formation
of BMP-15 homodimers [3] or the efficiency of the
processing and secretion of homodimers or their het-
erodimerization with GDF-9 [32]. The FecBB, Q249R
mutation in BMPR-1B, has also been hypothesized as a
partial "loss of function" mutation [21,57]. Indeed, using
a BMP-specific luciferase reporter in transfected HEK-293
cells, the presence of the Q249R mutation in BMPR-1B is
associated with a loss of responsiveness to BMP-4 [57].
This loss in receptor activity is also illustrated by the fact
that granulosa cells from homozygous FecBB carrier ewes
are less sensitive to the action of BMP-4 on proliferation
and inhibition of progesterone production than those
from non-carrier ewes [21,57].
3H-thymidine incorporation into sheep granulosa cells Figure 3
3H-thymidine incorporation into sheep granulosa 
cells. Granulosa cells from small antral follicles of 1–3 mm in 
diameter were incubated with 3H-thymidine for 2 h after 48 
h of culture in the presence of 3% fetal ovine serum with or 
without recombinant human BMP-2 (100 ng/ml), BMP-4 (50 
ng/ml), BMP-6 (100ng/ml), BMP-15 (200 ng/ml) or rat GDF-9 
(1000 ng/ml). Results represent the labeling index (percent-
age of 3H-thymidine-labelled cells). Data are expressed as 
percentages (mean ± SEM) of the labeling index of cells cul-
tured in control condition. Asterisk indicates significant dif-
ference (p < 0.05) compared with control.
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Thus, in sheep, it seems that a decrease in BMP system
activity leads to an increase in ovulation rate. Based on
this concept and the known role of BMP molecules during
folliculogenesis, a mechanism can be proposed to explain
the increase in ovulation rate due to "loss of function"
mutations in the BMP system (Fig. 4). Firstly, mutations
in Fec genes would likely impair the proliferative action of
BMPs from the first steps of folliculogenesis onwards. The
final consequence is the presence of follicles with a lower
number of granulosa cells in ovaries from mutated Fec car-
rier ewes [63,64]. Secondly, in the presence of loss of func-
tion mutations, the BMP inhibiting action on the FSH
pathway in granulosa cells is decreased, enabling a higher
FSH sensitivity [5,65] and an enhanced expression of
FSH-dependent markers of differentiation such as ster-
oidogenic enzymes genes, inhibin/activin subunits and
LH receptor in granulosa cells of antral follicles [63].
Accordingly, these markers of granulosa cells differentia-
tion appear in follicles of smaller size in mutated Fec gene
carriers compared to non-carriers. The increased sensitiv-
ity to gonadotropins of these follicles promotes their
selection and maintenance when circulating concentra-
tion of FSH is decreasing during the follicular phase. In
mutated Fec gene carriers, each of these selected follicles
contains a reduced number of granulosa cells and pro-
duces lower amounts of oestradiol and inhibin, but alto-
gether, these follicles produce the same amounts than
fewer wild-type follicles [5,26,63]. It is likely that the pos-
itive feedback of oestradiol on GnRH secretion is triggered
using the same oestradiol threshold in both carriers and
non-carriers of mutated Fec genes, allowing ovulation and
luteinization of numerous mature LH-responsive follicles
in mutated Fec gene carriers.
Schematic representation of the effects of a mutation in fecundity (Fec) gene on folliculogenesis and ovulation rate in sheep Figure 4
Schematic representation of the effects of a mutation in fecundity (Fec) gene on folliculogenesis and ovulation 
rate in sheep. The reduced activity of the BMP signaling system in the ovary of mutated Fec gene carrier (right) compared to 
non-carrier (left) ewes leads to decrease both the positive action of BMP on granulosa cell (GC) mitosis and its inhibiting action 
on FSH sensitivity. The consequence is the presence of smaller antral follicles with a reduced number of granulosa cells exhib-
iting a higher FSH sensitivity, leading to an advance in follicular maturation as attested by precocious LH receptor expression. 
The smaller matured follicles present in mutated Fec gene carrier each produce reduced amounts of oestradiol (E2) and inhibin, 
but altogether they produce the same amounts than one larger wild-type follicle. Consequently, the same endocrine dialog can 
establish between the ovaries and the central nervous system of both genotypes that leads to the selection and ovulation of 
numerous smaller follicles in mutated Fec gene carrier.
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Sheep fecundity gene as fecundity genes for 
other mammals
As a basis for comparison, targeted invalidation in mouse
has been generated for the identified fecundity genes in
sheep. Unlike mutated FecX/BMP-15 homozygous ewes,
Bmp15 null female mice (Bmp15-/-) are fertile but exhibit
a slight decrease in ovulation rate with minimal ovarian
histopathological defects [66]. In contrast, Gdf9-/- null
female mice are sterile [67]. Ovarian folliculogenesis of
Gdf9-/- mice is blocked at the primary follicle stage mim-
icking surprisingly the ovarian phenotype of the
homozygous mutated FecX/BMP-15 sheep. However, it
differs from the phenotype of the homozygous mutated
FecG/GDF-9 sheep in which the follicular development is
stopped at the small antral stage [9,10]. Altogether, these
results could indicate that Gdf9 in mouse and BMP-15 in
sheep play the same crucial mitogenic role in the primary-
secondary follicle transition. Thus, Bmp15 is dispensable
and Gdf9 obligatory for normal folliculogenesis and ovu-
lation in mouse. In contrast, both GDF-9 and BMP-15 are
essential in the sheep as attested by the sterility of both
homozygous mutated FecX and FecG ewes [3,9] and wild-
type ewes immunized against GDF-9 and BMP-15
[33,68]. Mice invalidated for Bmpr-1b gene have also
been established [69]. In striking contrast with FecB/
BMPR-1B mutated hyperprolific sheep, bmpr-1b-/- null
mice are infertile due to cumulus expansion and postovu-
latory defects, but without alteration of follicle recruit-
ment and maturation. These discrepancies might be due
to species differences, and/or to the nature of the altera-
tion (point mutation vs. deletion). Nevertheless, it should
be noted that neither Bmp15 nor Gdf9 or Bmpr-1b inval-
idated mouse models exhibit at heterozygous or
homozygous state an increase in ovulation rate as
observed in sheep.
From the discovery of sheep fecundity genes and their role
in regulating ovarian folliculogenesis, several research
groups have focused on BMP-15 and GDF-9 alterations
associated with human ovarian pathologies such as pre-
mature ovarian failure (POF) or polycystic ovary syn-
drome (PCO) [46,70,71]. At that time, a decreased
expression of GDF-9 in oocytes of women with PCO [71]
and an inactivating mutation in the BMP-15 proregion
(Y235C) associated with POF have been described [46].
For the future, emerging systematic sequencing programs
of these two genes in POF and PCO patients are operative
with the perspective to discover new mutations.
BMP dose dependent effect, from sterility to 
polyovulation
As shown previously, the Booroola BMPR-1B mutation
has additive effects on ovulation rate. Moreover, cross-
breeding of sheep carrying one copy of a FecX/BMP-15
mutation with those carrying the FecB/BMPR-1B muta-
tion exhibits a multiplicative effect on ovulation rate.
Finally, one copy of a FecX/BMP-15 mutation together
with one copy of the FecG/GDF-9 mutation suggests that
the effect of the two genes is additive on ovulation rate
(reviewed in [2]). Thus, it appears that in sheep, the more
the BMP system activity is reduced, the more the ovula-
tion rate increases (Fig. 5). At both extremities of this con-
trol might appear ovarian dysfunction and then sterility.
In one side, total loss of BMP-15 or GDF-9 leads to arrest
in folliculogenesis, while on the other side, one could
hypothesize that hyperactivity of the BMP system might
lead to non-fully mature anovulatory follicles (Fig. 5).
Accordingly,  in vivo treatment with BMP-7 markedly
decreases ovulation rate in mice [59]. Whether this BMP
"tune" in ovine species is the general mechanism that con-
trols ovulation rate among mammals remains to be deter-
mined. In this way, the BMP-15 example is very
interesting. Indeed, it appears that in the mono-ovulating
human species, two functional copies of BMP-15 are
required, since the presence of a heterozygous mutation is
sufficient for ovarian failure. In ovine species, with a large
ovulation rate ranging, only one copy is sufficient,
homozygous mutation leading to ovarian function arrest.
Finally, in a poly-ovulating species such as the mouse,
with ovulation rate about 10, BMP-15 is dispensable.
However, BMP-15 is present and expressed in oocytes of
these three species. As a possible explicative mechanism,
Hashimoto et al. [72] have shown that the mouse BMP-15
peptide is much less efficiently processed and secreted
than the human peptide by the same transfected cells.
Whether this deficient processing occurs also with the por-
cine BMP-15 will be of great interest in this highly poly-
ovulating species where a functional BMP system in the
ovary has also been demonstrated [73,74].
Linked to this BMP dose-dependence concept, ovaries
express a wide variety of genes of the BMP system, raising
the question of the redundancy and the relative impor-
tance of each of them along the folliculogenesis process
within a given species and the regulation of ovulation
quota between species with different ovulation rates. The
answers to these questions are part of future field of inves-
tigation for the years to come.
Conclusion
Since 1980, when Piper and Bindon [14] proposed that
the exceptional fecundity of the Booroola Merino sheep
may in part result from the action of a single major gene,
the use of sheep with genetic mutation affecting ovulation
rate has provided exceptional tools in the field of female
reproductive biology. With the identification of the nature
and the physiological role of fecundity genes, BMP-15,
GDF-9 and BMPR-1B, two new major concepts were born.
First, the BMP system, originally described as inducer of
osteogenesis and chondrogenesis and implicated in earlyReproductive Biology and Endocrinology 2006, 4:20 http://www.rbej.com/content/4/1/20
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developmental events, now represents a key system as
gonadotropins or IGFs systems, in the control of ovarian
folliculogenesis and ovulation rate. Second, the oocyte,
acting through specific secreted proteins, is not only
implicated in follicular growth but also in the control of
the number of ovulating follicles [75].
Numerous other major genes affecting ovulation rate in
sheep remain to be identified [2]. Their identification may
confirm the exceptional role of the BMP system or may
point at genes independent of BMP signaling with main
effects at the level of the ovary or the central nervous sys-
tem or both.
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